STOCK TITAN

PETLIFE PHARMS INC - $PTLF STOCK NEWS

Welcome to our dedicated page for PETLIFE PHARMS news (Ticker: $PTLF), a resource for investors and traders seeking the latest updates and insights on PETLIFE PHARMS stock.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect PETLIFE PHARMS's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of PETLIFE PHARMS's position in the market.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-8.33%
Tags
none
PETLIFE PHARMS INC

OTC:PTLF

PTLF Rankings

PTLF Stock Data

393.50k
72.27M
6.43%
Drug Manufacturers - Specialty & Generic
Healthcare
United States of America
Carson City

About PTLF

petlife pharmaceuticals, inc., (otc:ptlf) is launching a new generation of all natural veterinary cancer medications and nutraceuticals, based on the venom of the caribbean blue scorpion. this treatment is based on the same patented formula and production processes used in the human formulation known as escozine™. petlife has licensed the worldwide rights to formulate, package and market a new product line, "vitalzul for pets™"​. the company’s mission is to bring several non-invasive treatments to market with the goal of improving the quality of life in our companion animals. the anticipated registration of an fda approved drug, “vitalzul™”, for the treatment of cancer in animals, as well as the introduction of nutraceuticals, food, and pet treats, are all in the works today.